Showing 1 - 2 results of 2 for search '"b-cell depletion"', query time: 0.03s Refine Results
  1. 1
    CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®

    CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BI... by S. M. Alekseev, K. D. Kaplanov, R. A. Ivanov, E. V. Chernyaeva

    Published 2015-04-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India

    Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India by Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee

    Published 2021-01-01
    Subjects: “…b cell depletion therapy…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: